Security key
09073Q105
- Security type / class
- Equity / ADSs
- Total 13F shares
- 333,825
- Total 13F value
- $389,000
- Share change
- +9,042
- SEC-reported price per share
- $1.17
- Number of holders
- 13
- Value change
- -$12,455
- Number of buys
- 4
- Number of sells
- 8
- Shares outstanding
- 592,878
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
13
Top holders
10
BVXV full security history
Ownership snapshot
Full 13F holder table
Scinai Immunotherapeutics Ltd. SEC filings
Scinai Immunotherapeutics Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of BVXV - Scinai Immunotherapeutics Ltd. - ADSs (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SUSQUEHANNA INTERNATIONAL...
Disclosed value leader
SUSQUEHANNA INTERNATIONAL...
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 9.5%
Showing 1-6 of 15 holder rows.
Quick read
SUSQUEHANNA INTERNATIONAL GROUP, LLP leads the comparable SEC ownership view at 9.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SUSQUEHANNA INTERNATIONAL GROUP, LLP's linked filing trail.
Comparable ownership
Top 5
SUSQUEHANNA INTERNATIONAL GROUP, LLP
9.5%
ENVESTNET ASSET MANAGEMENT INC
8.4%
TRUE Private Wealth Advisors
8.3%
MORGAN STANLEY
8%
CITADEL ADVISORS LLC
7.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
9.5%
|
$94,000
56,348 shares
|
— | 31 Mar 2022 |
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
8.4%
|
$83,000
50,005 shares
|
— | 31 Mar 2022 |
| TRUE Private Wealth Advisors |
13F
Company
|
8.3%
|
$79,000
49,500 shares
|
— | 31 Mar 2022 |
| MORGAN STANLEY |
13F
Company
|
8%
|
$79,000
47,632 shares
|
— | 31 Mar 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
7.1%
|
$70,000
42,225 shares
|
— | 31 Mar 2022 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
3.9%
|
$38,000
22,922 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
333,825
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
15
Q2 2022 holders
13
Holder diff
-2
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|